 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
extracellular region
|
3 terms
|
 |
|
Biological process
|
negative regulation of growth of symbiont in host
|
51 terms
|
 |
|
Biochemical function
|
cytokine activity
|
3 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
281:35088-35096
(2006)
|
|
PubMed id:
|
|
|
|
|
| |
|
Conformational changes mediate interleukin-10 receptor 2 (IL-10R2) binding to IL-10 and assembly of the signaling complex.
|
|
S.I.Yoon,
N.J.Logsdon,
F.Sheikh,
R.P.Donnelly,
M.R.Walter.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Interleukin-10 receptor 2 (IL-10R2) is a critical component of the
IL-10.IL-10R1.IL-10R2 complex which regulates IL-10-mediated immunomodulatory
responses. The ternary IL-10 signaling complex is assembled in a sequential
order with the IL-10.IL-10R1 interaction occurring first followed by engagement
of the IL-10R2 chain. In this study we map the IL-10R2 binding site on IL-10
using surface plasmon resonance and cell-based assays. Critical IL-10R2 binding
residues are located in helix A adjacent to the previously identified IL-10R1
recognition surface. Interestingly, IL-10R2 binding residues located in the
N-terminal end of helix A exhibit large structural differences between unbound
cIL-10 and cIL-10.IL-10R1 crystal structures. This suggests IL-10R1-induced
conformational changes regulate IL-10R2 binding and assembly of the ternary
IL-10.IL-10R1.IL-10R2 complex. The basic mechanistic features of the assembly
process are likely shared by six additional class-2 cytokines (viral IL-10s,
IL-22, IL-26, IL-28A, IL28B, and IL-29) to promote IL-10R2 binding to six
additional receptor complexes. These studies highlight the importance of
structure in regulating low affinity protein-protein interactions and IL-10
signal transduction.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
FIGURE 3. Characterization of cIL-10 dimer IL-10R2 binding
site mutants. A, dissociation constants (K[d]) determined by SPR
for cIL-10 mutant-sIL-10R1 interactions are plotted as black
bars. Schematic diagram depicting the kinetic SPR experiment
used to obtain the values is shown to the right of the figure.
B, relative IL-10R2 binding by cIL-10 mutants. IL-10R2 binding
to cIL-10 or cIL-10 mutant-sIL-10R1 complexes were evaluated in
a single point assay normalized to the wild-type
cIL-10·IL-10R2 response. A schematic diagram depicting
the SPR experimental setup used to obtain the data is shown to
the right of the figure. The results for both assays are
expressed as the mean of multiple experiments ± S.D.
Statistically significant differences (p < 0.05) between cIL-10
and cIL-10 mutants in the assays are denoted by asterisks (^*).
C, Western blot showing the ability of cIL-10 dimer mutants to
induce phosphorylation of STAT3 in primary human monocytes. pY,
phosphotyrosine.
|
 |
Figure 5.
FIGURE 5. Comparison of sIL-10R2 binding sites. A, helices
A and D from cIL-10 (magenta) and cmvIL-10 (blue) are shown.
cIL-10 side-chain residues around the IL-10R2 binding site are
gold. Structurally similar side-chain residues for cmvIL-10 are
white. B, helices A and D from cIL-10 (magenta) and IL-22
(green) are shown. cIL-10 side-chain residues around the IL-10R2
binding site are gold as described for A. Side chains that
contribute to the IL-22·IL-10R2 binding interface are
shown in cyan. The labels of the most energetically important
residues are circled.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2006,
281,
35088-35096)
copyright 2006.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
W.Ouyang,
S.Rutz,
N.K.Crellin,
P.A.Valdez,
and
S.G.Hymowitz
(2011).
Regulation and functions of the IL-10 family of cytokines in inflammation and disease.
|
| |
Annu Rev Immunol, 29,
71.
|
 |
|
|
|
|
 |
A.Zdanov
(2010).
Structural analysis of cytokines comprising the IL-10 family.
|
| |
Cytokine Growth Factor Rev, 21,
325-330.
|
 |
|
|
|
|
 |
B.Dénes,
I.Fodor,
and
W.H.Langridge
(2010).
Autoantigens plus interleukin-10 suppress diabetes autoimmunity.
|
| |
Diabetes Technol Ther, 12,
649-661.
|
 |
|
|
|
|
 |
D.B.Trivella,
J.R.Ferreira-Júnior,
L.Dumoutier,
J.C.Renauld,
and
I.Polikarpov
(2010).
Structure and function of interleukin-22 and other members of the interleukin-10 family.
|
| |
Cell Mol Life Sci, 67,
2909-2935.
|
 |
|
|
|
|
 |
K.Witte,
E.Witte,
R.Sabat,
and
K.Wolk
(2010).
IL-28A, IL-28B, and IL-29: promising cytokines with type I interferon-like properties.
|
| |
Cytokine Growth Factor Rev, 21,
237-251.
|
 |
|
|
|
|
 |
R.P.Donnelly,
F.Sheikh,
H.Dickensheets,
R.Savan,
H.A.Young,
and
M.R.Walter
(2010).
Interleukin-26: an IL-10-related cytokine produced by Th17 cells.
|
| |
Cytokine Growth Factor Rev, 21,
393-401.
|
 |
|
|
|
|
 |
R.Sabat,
G.Grütz,
K.Warszawska,
S.Kirsch,
E.Witte,
K.Wolk,
and
J.Geginat
(2010).
Biology of interleukin-10.
|
| |
Cytokine Growth Factor Rev, 21,
331-344.
|
 |
|
|
|
|
 |
S.I.Yoon,
B.C.Jones,
N.J.Logsdon,
B.D.Harris,
A.Deshpande,
S.Radaeva,
B.A.Halloran,
B.Gao,
and
M.R.Walter
(2010).
Structure and mechanism of receptor sharing by the IL-10R2 common chain.
|
| |
Structure, 18,
638-648.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.A.McElroy,
J.A.Dohm,
and
S.T.Walsh
(2009).
Structural and biophysical studies of the human IL-7/IL-7Ralpha complex.
|
| |
Structure, 17,
54-65.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
H.H.Gad,
C.Dellgren,
O.J.Hamming,
S.Vends,
S.R.Paludan,
and
R.Hartmann
(2009).
Interferon-lambda is functionally an interferon but structurally related to the interleukin-10 family.
|
| |
J Biol Chem, 284,
20869-20875.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
B.C.Jones,
N.J.Logsdon,
and
M.R.Walter
(2008).
Structure of IL-22 bound to its high-affinity IL-22R1 chain.
|
| |
Structure, 16,
1333-1344.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.J.Ellis,
and
S.Jones
(2008).
Evaluating conformational changes in protein structures binding RNA.
|
| |
Proteins, 70,
1518-1526.
|
 |
|
|
|
|
 |
M.de Oliveira Neto,
J.R.Ferreira,
D.Colau,
H.Fischer,
A.S.Nascimento,
A.F.Craievich,
L.Dumoutier,
J.C.Renauld,
and
I.Polikarpov
(2008).
Interleukin-22 forms dimers that are recognized by two interleukin-22R1 receptor chains.
|
| |
Biophys J, 94,
1754-1765.
|
 |
|
|
|
|
 |
S.G.Gruber,
M.Gloria Luciani,
P.Grundtner,
A.Zdanov,
and
C.Gasche
(2008).
Differential signaling of cmvIL-10 through common variants of the IL-10 receptor 1.
|
| |
Eur J Immunol, 38,
3365-3375.
|
 |
|
|
|
|
 |
R.L.Rich,
and
D.G.Myszka
(2007).
Survey of the year 2006 commercial optical biosensor literature.
|
| |
J Mol Recognit, 20,
300-366.
|
 |
|
|
|
|
 |
S.I.Yoon,
and
M.R.Walter
(2007).
Identification and characterization of a +1 frameshift observed during the expression of Epstein-Barr virus IL-10 in Escherichia coli.
|
| |
Protein Expr Purif, 53,
132-137.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|